Literature DB >> 16757155

Effect of antidepressant drugs on 6-OHDA-treated mice in the FST.

F Chenu1, E Dailly, M Bourin.   

Abstract

There is growing evidence suggesting that dopamine could be indirectly involved in the appearance of behavioural effects of antidepressants. In this study, we induced a partial (over 70%) and non-reversible depletion of dopamine-containing neurons in mice by i.c.v. infusion of 6-OHDA. Then, we compared the antidepressant-like effect of drugs (citalopram, paroxetine, desipramine and imipramine) with or without dopamine depletion in the mice forced swimming test. Our results clearly show that lesion with 6-OHDA does not modify the response of mice to desipramine and imipramine, whereas dopamine depletion abolished the antidepressant-like effect of citalopram and paroxetine. It could then be suggested that antidepressant-like effect of selective serotonin reuptake inhibitors (paroxetine and citalopram) in the mice FST requires the activation of dopaminergic pathways to occur.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16757155     DOI: 10.1016/j.euroneuro.2006.04.006

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  6 in total

Review 1.  Application of Neurotoxin-Induced Animal Models in the Study of Parkinson's Disease-Related Depression: Profile and Proposal.

Authors:  Ya-Kui Mou; Li-Na Guan; Xiao-Yan Yao; Jia-Hui Wang; Xiao-Yu Song; Yong-Qiang Ji; Chao Ren; Shi-Zhuang Wei
Journal:  Front Aging Neurosci       Date:  2022-05-13       Impact factor: 5.702

2.  Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.

Authors:  Michel Bourin; Franck Chenu; Corina Prica; Martine Hascoët
Journal:  Psychopharmacology (Berl)       Date:  2009-06-11       Impact factor: 4.530

3.  Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.

Authors:  Franck Chenu; Denis J P David; Isabelle Leroux-Nicollet; Erwan Le Maître; Alain M Gardier; Michel Bourin
Journal:  J Psychiatry Neurosci       Date:  2008-11       Impact factor: 6.186

4.  Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits.

Authors:  Miguel M Carvalho; Filipa L Campos; Bárbara Coimbra; José M Pêgo; Carla Rodrigues; Rui Lima; Ana J Rodrigues; Nuno Sousa; António J Salgado
Journal:  Mol Neurodegener       Date:  2013-04-26       Impact factor: 14.195

5.  Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson's Disease.

Authors:  Motoki Okano; Kazue Takahata; Junya Sugimoto; Shizuko Muraoka
Journal:  Front Behav Neurosci       Date:  2019-08-02       Impact factor: 3.558

6.  Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial.

Authors:  Olof R Hjorth; Andreas Frick; Malin Gingnell; Johanna M Hoppe; Vanda Faria; Sara Hultberg; Iman Alaie; Kristoffer N T Månsson; Jörgen Rosén; Margareta Reis; Kurt Wahlstedt; My Jonasson; Mark Lubberink; Gunnar Antoni; Mats Fredrikson; Tomas Furmark
Journal:  Transl Psychiatry       Date:  2021-11-03       Impact factor: 6.222

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.